Effect of static pressure on acoustic transmittance of Albunex® microbubble suspensions

Journal of the Acoustical Society of America

Volumn 99, Issue 4 I, 1996, Pages 2403-2408

  Brayman, Andrew A ^a   Azadniv, Mitra ^a   Miller, Morton W ^a   Meltzer, Richard S ^a  

^a UNIVERSITY OF ROCHESTER SCHOOL OF MEDICINE AND DENTISTRY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALBUMIN; ALBUNEX; ECHO CONTRAST MEDIUM;

ACOUSTICS; ARTICLE; CONTRAST ENHANCEMENT; DRUG STABILITY; ECHOCARDIOGRAPHY; HYDROSTATIC PRESSURE; PHARMACEUTICS; PRIORITY JOURNAL; SPECTROPHOTOMETRY; SUSPENSION; ULTRASOUND;

ACOUSTICS; ALBUMINS; ANIMALS; CATTLE; CONTRAST MEDIA; HEART; PRESSURE; SUSPENSIONS; TEMPERATURE; TIME FACTORS;

EID: 0029932815     PISSN: 00014966     EISSN: None     Source Type: Journal    
DOI: 10.1121/1.415428     Document Type: Article

References (15)

1. J. R. Shapiro, S. A. Reisner, G. S. Lichtenberg, and R. S. Meltzer, "Intravenous contrast echocardiography with use of sonicated albumin in humans: systolic disappearance of left ventricular contrast after transpulmonary transmission," J. Am. Coll. Cardiol. 16, 1603-1607 (1990).
2. V. Mor-Avi, S. G. Shroff, K. A. Robinson, A. F. Ng, B. P. Cholley, R. H. Marcus, and R. M. Lang, "Effect of left ventricular pressure on sonicated albumin microbubbles: evaluation using an isolated rabbit heart model," J. Am. Coll. Cardiol. 24, 1779-1785 (1994).
3. M. W. Keller, W. P. Glasheen, and S.Kaul, "Albunex: a safe and effective commercially produced agent for myocardial contrast echocardiography." J. Am. Soc. Echocardiogr. 2, 48-52 (1989).
4. H. J. Bleeker, K. K. Shung, and J. L. Barnhart, "Ultrasonic characterization of Albunex®, a new contrast agent," J. Acoust. Soc. Am. 87, 1792-1797 (1990).
5. B. F. Vandenberg and H. E. Melton, "Acoustic lability of albumin microspheres," J. Am. Soc. Echocardiogr. 7, 582-589 (1994).
6. S. M. Powsner, M. W. Keller, J. Sanie, and S. B. Feinstein, "Quantitation of echo contrast effects," Am. J. Physiol. Imaging 1, 124-128 (1986).
7. P. A. Heidenreich, J. G. Wiencek, J. G. Zarnoff, S. Aronson, L. J. Segil, P. V. Harper, and S. B. Feinstein, "In vitro calculation of flow by use of contrast ultrasonography," J. Am. Soc. Echocardiogr. 6, 51-61 (1993).
8. C. Vuille, M. Nidorf, R. L. Morrissey, J. B. Newell, A. E. Weyman, and M. H. Picard, "Effect of static pressure on the disappearance rate of specific echocardiographic contrast agents," J. Am. Soc. Echocardiogr. 7, 347-354 (1994).
9. S. Gottlieb, A. Ernst, and R. S. Meltzer, "Effect of pressure on echocardiographic videodensity from sonicated albumin: an in vitro model," J. Ultrasound Med. 14, 109-116 (1995).
10. N. DeJong, F. J. ten Cate, W. B. Vletter, and J. R. T. C. Roelandt, "Quantification of transpulmonary echocontrast effects," Ultrasound Med. Biol. 19, 279-288 (1993).
11. B. F. Vandenberg, "Reproducibility of albumin microbubble backscatter measurement: influence of acoustic output [Abstract]," Clin. Res. 38, 887A (1990).
12. R. A. Wray, M. A. Quinones, W. A. Zoghbi, and J. Cheirif, "Relation of mean pixel intensity to concentration of sonicated albumin microspheres: effects of ultrasound system settings," Clin. Cardiol. 14, 23-28 (1991).
13. F. S. Villanueva, W. P. Glasheen, J. Sklenar, A. R. Jayaweera, and S. Kaul, "Successful and reproducible myocardial opacification during two-dimensional echocardiography from right heart injection of contrast," Circulation 85, 1557-1564 (1992).
14. R. Shandras, D. J. Sahn, G. Bales, T. Elkadi, K.-K. Yau, and M. Gharib, "Persistence of albunex (ALB) ultrasound contrast agent: in vitro study of the effects of pressure and acoustic power on particle size, and the duration of contrast and Doppler enhancement [Abstract]," Circulation 82, Suppl. III, 95 (1990).
15. M. W. Miller, M. Azadniv, Y. Doida, and A. A. Brayman, "Effect of a stabilized microbubble contrast agent on CW ultrasound induced red blood cell lysis in vitro," Echocardiography 12, 1-11 (1995).